Core Illumina — Consolidated capital expenditures
Illumina Core Illumina — Consolidated capital expenditures remained flat by 0.0% to $37.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $34.25M to $37.00M. Over 4 years (FY 2021 to FY 2025), Core Illumina — Consolidated capital expenditures shows a downward trend with a -7.4% CAGR.
Analysis
How to read this metric
Higher spending indicates investment in future growth and capacity, whereas lower spending may signal a focus on cash preservation or a mature asset cycle.
Detailed definition
This measures the funds used by the Core Illumina segment to acquire, upgrade, and maintain physical assets such as manu...
Peer comparison
Commonly tracked in capital-intensive industries; peers in biotech instrumentation show similar cycles of investment based on product launch cadences.
ilmn_segment_core_illumina_consolidated_capital_expendituresHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $201.00M | $262.00M | $183.00M | $137.00M | $148.00M |
| YoY Change | — | +30.3% | -30.2% | -25.1% | +8.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Illumina's core illumina — consolidated capital expenditures?
- Illumina (ILMN) reported core illumina — consolidated capital expenditures of $37.00M in Q4 2025.
- How has Illumina's core illumina — consolidated capital expenditures changed year-over-year?
- Illumina's core illumina — consolidated capital expenditures increased by 8.0% year-over-year, from $34.25M to $37.00M.
- What is the long-term trend for Illumina's core illumina — consolidated capital expenditures?
- Over 4 years (2021 to 2025), Illumina's core illumina — consolidated capital expenditures has grown at a -7.4% compound annual growth rate (CAGR), from $201.00M to $148.00M.
- What does core illumina — consolidated capital expenditures mean?
- The total cash spent by the segment to purchase or improve long-term physical assets.